Benzinga | Sep 8, 2020 12:29PM EDT

Needham Maintains Buy on Albireo Pharma, Raises Price Target to $68

Needham maintains Albireo Pharma (NASDAQ:ALBO) with a Buy and raises the price target from $50 to $68.